Are Corneal Epithelial Defects Related to Changes in Ocular Bacterial Flora in Patients With ANLDO

NCT ID: NCT02234700

Last Updated: 2014-09-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-08-31

Study Completion Date

2015-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison between patients with nasolacrimal duct obstruction and healthy patients and the influence of their bacterial flora on the corneal epithelium.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Any patient with nasolacrimal duct obstruction above the age of 18 Comparing changes in their bacterial ocular flora to healthy patients without obstruction and above 18 years of age

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Nasolacrimal Duct Obstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older, nasolacrimal duct obstruction

Exclusion Criteria

* younger then 18 years of age
* ocular infections
* patients after repair of lacrimal duct surgery
* systemic active diseases
* patients taking medication that are know to influence bacterial flora of the eye
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Western Galilee Hospital-Nahariya

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yanir Kassif, M.D

Role: STUDY_CHAIR

Medical Center of the Galilee

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Western Galileeh Hospital

Naharya, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

abdelhakim Ayub, MD

Role: CONTACT

0502999110

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Abdelhakim ayub, MD

Role: primary

0502999110

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TASMC-14-AA-0071-CTIL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ocular Surface Microbiome
NCT02298881 COMPLETED
Steroids for Corneal Ulcers Trial
NCT00324168 COMPLETED PHASE4